• ورود به سامانه
      مشاهده مورد 
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Iranian Journal of Pharmaceutical Research
      • Volume 19, Issue 2
      • مشاهده مورد
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Iranian Journal of Pharmaceutical Research
      • Volume 19, Issue 2
      • مشاهده مورد
      JavaScript is disabled for your browser. Some features of this site may not work without it.

      Fraction Bioactivity Screening of Mulberry Leaf and Two Flavonoids in Combination with Cisplatin on Human Gastric Adenocarcinoma Cells

      (ندگان)پدیدآور
      Ghavami, GhazalehMuhammadnejad, SamadAmanpour, SaeedSardari, Soroush
      Thumbnail
      دریافت مدرک مشاهده
      FullText
      اندازه فایل: 
      1.381 مگابایت
      نوع فايل (MIME): 
      PDF
      نوع مدرک
      Text
      Research article
      زبان مدرک
      English
      نمایش کامل رکورد
      چکیده
      The successful therapy strategy of gastric cancer is defined as devastating of the cancerous cells without exposing systematic toxicity and undesirable side effects. One strategy to overcome cancer treatment related difficulties could be combination therapy with natural products with anticancer drugs to introduce effective antitumor effects in addition to reduction of undesirable side effects. On the subject of the pointed fact, different extracts of mulberry leaf, isoquercetin and rutin as reported extracted flavonoids from M. alba in single doses as well as in combination with cisplatin against gastric cancer cell line were prescribed. This innovative treatment led to inspiration of cytotoxicity on gastric cancer in synergistic manner. The findings anticipated that these herbal products have exceptional potential for future gastric cancer therapy investigations.
      کلید واژگان
      Mulberry
      Cisplatin
      Rutin
      Isoquercetin
      Combination effect
      Gastric Cancer

      شماره نشریه
      2
      تاریخ نشر
      2020-06-01
      1399-03-12
      ناشر
      School of Pharmacy, Shahid Beheshti University of Medical Sciences
      سازمان پدید آورنده
      Drug Design and Bioinformatics Unit, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
      Cell-Based Therapies Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
      Cancer Biology Research center, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
      Drug Design and Bioinformatics Unit, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.

      شاپا
      1735-0328
      1726-6890
      URI
      https://dx.doi.org/10.22037/ijpr.2020.1101087
      http://ijpr.sbmu.ac.ir/article_1101087.html
      https://iranjournals.nlai.ir/handle/123456789/312331

      مرور

      همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

      حساب من

      ورود به سامانهثبت نام

      تازه ترین ها

      تازه ترین مدارک
      © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
      تماس با ما | ارسال بازخورد
      قدرت یافته توسطسیناوب